These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 32716269)
1. Vinblastine for elderly and frail patients with Hodgkin lymphoma. Meynard L; Galtier J; Favre S; Debus L; Lascaux A; Dilhuydy MS; Gros FX; Sauvezie M; Milpied N; Bouabdallah K; Dimicoli S Leuk Lymphoma; 2020 Dec; 61(13):3239-3242. PubMed ID: 32716269 [No Abstract] [Full Text] [Related]
2. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen? Canellos GP; Duggan D; Johnson J; Niedzwiecki D J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636 [No Abstract] [Full Text] [Related]
3. Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial. Arakelyan N; Jais JP; Delwail V; Brière J; Moles-Moreau MP; Sénécal D; Berthou C; Desablens B; Colonna P; Andrieu JM; Cancer; 2010 Sep; 116(17):4054-62. PubMed ID: 20564152 [TBL] [Abstract][Full Text] [Related]
4. [Management of lymphoma with respect to pathologic classification: updates and controversies]. Zhu J; Song YQ Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):724-7. PubMed ID: 20079009 [No Abstract] [Full Text] [Related]
5. Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma. D'Arco AM; Califano C; Barone L; Belsito Petrizzi V; Iovino V; Langella M; Maglione V; Rivellini F; De Lorenzo S Br J Haematol; 2015 Nov; 171(4):662-5. PubMed ID: 25873239 [No Abstract] [Full Text] [Related]
6. How can outcomes be improved for older patients with Hodgkin lymphoma? Evens AM; Hong F J Clin Oncol; 2013 Apr; 31(12):1502-5. PubMed ID: 23509323 [No Abstract] [Full Text] [Related]
7. Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly. Stamatoullas A; Brice P; Bouabdallah R; Mareschal S; Camus V; Rahal I; Franchi P; Lanic H; Tilly H Br J Haematol; 2015 Jul; 170(2):179-84. PubMed ID: 25891777 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option. Canellos GP J Clin Oncol; 2005 Jul; 23(21):4574-6. PubMed ID: 15837972 [No Abstract] [Full Text] [Related]
9. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV]. Lopez M Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542 [No Abstract] [Full Text] [Related]
10. Chemotherapy alone for early-stage Hodgkin's lymphoma. Straus DJ N Engl J Med; 2012 Feb; 366(5):470-1. PubMed ID: 22149920 [No Abstract] [Full Text] [Related]
11. Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine Shortage. Torka P; Przespolewski E; Evens AM JCO Oncol Pract; 2022 Jul; 18(7):491-497. PubMed ID: 35254922 [TBL] [Abstract][Full Text] [Related]
14. Controversies in the treatment of early-stage Hodgkin's lymphoma. Longo DL; Armitage JO N Engl J Med; 2015 Apr; 372(17):1667-9. PubMed ID: 25901431 [No Abstract] [Full Text] [Related]
15. Advanced Hodgkin's disease: ABVD is better, yet is not good enough! Diehl V J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791 [No Abstract] [Full Text] [Related]
16. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease. Williamson PJ; de Berker D Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077 [No Abstract] [Full Text] [Related]